Broker Tips
Broker tips: Hikma Pharmaceuticals, Judges Scientific, Michelmersh Brick
Berenberg upgraded Hikma Pharmaceuticals on Tuesday and lifted the price target to 2,400. 0p from 2,100. 0p as it said "clear progress" had been made.
Canaccord Genuity lowers target price on Michelmersh Brick Holdings
Analysts at Canaccord Genuity lowered their target price on building products manufacturer Michelmersh Brick Holdings from 180. 0p to 170. 0p on Tuesday following the group's interim trading results.
Jefferies starts Judges Scientific at ‘buy’ after share price correction
Jefferies initiated coverage on Judges Scientific on Tuesday with a ‘buy’ rating and 12,230p price target, as it said the valuation is more attractive following the recent share price correction, particularly if potential M&A upside is considered.
Berenberg upgrades Hikma Pharmaceuticals to ‘buy’
Berenberg upgraded Hikma Pharmaceuticals on Tuesday and lifted the price target to 2,400p from 2,100p as it said "clear progress" had been made.
Broker tips: Rightmove, Bodycote
Shore Capital reiterated its 'buy' rating on Rightmove on Monday after Australia's REA Group confirmed it was considering an offer for the UK property platform, highlighting the opportunities for shareholders whether or not a takeover happens.
Shore Capital sticks with 'buy' for Rightmove amid REA takeover speculation
Shore Capital has reiterated a 'buy' rating on Rightmove after Australia's REA Group confirmed it was considering an offer for the UK property platform, highlighting the opportunities for shareholders whether or not a takeover happens.
Berenberg starts coverage of Bodycote at ‘buy’
Berenberg initiated coverage of Bodycote on Monday with a ‘buy’ rating and "conservatively set" 800p price target.